BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26495770)

  • 1. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial.
    Reid AM; McNamara JP; Murphy TK; Guzick AG; Storch EA; Goodman WK; Geffken GR; Bussing R
    J Psychiatr Res; 2015 Dec; 71():140-7. PubMed ID: 26495770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
    Storch EA; Bussing R; Small BJ; Geffken GR; McNamara JP; Rahman O; Lewin AB; Garvan CS; Goodman WK; Murphy TK
    Behav Res Ther; 2013 Dec; 51(12):823-9. PubMed ID: 24184429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
    Bloch MH; Storch EA
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
    March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
    JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
    Skarphedinsson G; Weidle B; Thomsen PH; Dahl K; Torp NC; Nissen JB; Melin KH; Hybel K; Valderhaug R; Wentzel-Larsen T; Compton SN; Ivarsson T
    Eur Child Adolesc Psychiatry; 2015 May; 24(5):591-602. PubMed ID: 25239489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
    Ghobadian A; Mokhtari S; Shariati B; Kamalzadeh L; Shati M; Eftekhar Ardebili M; Yarahmadi M; Shalbafan M
    BMC Pharmacol Toxicol; 2022 Sep; 23(1):73. PubMed ID: 36167636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
    Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
    Storch EA; Lehmkuhl H; Geffken GR; Touchton A; Murphy TK
    Depress Anxiety; 2008; 25(2):172-4. PubMed ID: 17340610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
    Goldstein RB; Storch EA; Lehmkuhl H; Geffken GR; Goodman WK; Murphy TK
    Depress Anxiety; 2009; 26(1):E23-5. PubMed ID: 19067320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder.
    Asbahr FR; Castillo AR; Ito LM; Latorre MR; Moreira MN; Lotufo-Neto F
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1128-36. PubMed ID: 16239861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.
    Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M
    BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.
    Meyer JM; McNamara JP; Reid AM; Storch EA; Geffken GR; Mason DM; Murphy TK; Bussing R
    Child Psychiatry Hum Dev; 2014; 45(2):163-72. PubMed ID: 23756717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid Obsessive-Compulsive Disorder and Attention Deficit/Hyperactivity Disorder: Two Case Studies.
    Taormina SP; Galloway MP; Rosenberg DR
    J Dev Behav Pediatr; 2016; 37(6):491-5. PubMed ID: 27011005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder.
    Sousa MB; Isolan LR; Oliveira RR; Manfro GG; Cordioli AV
    J Clin Psychiatry; 2006 Jul; 67(7):1133-9. PubMed ID: 16889458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial.
    Franklin ME; Kozak MJ; Cashman LA; Coles ME; Rheingold AA; Foa EB
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):412-9. PubMed ID: 9549962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.